Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-02-04

Clinical Trial Update: To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial compared the cost-effectiveness of olanzapine versus haloperidol for schizophrenia (including schizoaffective disorder) and has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Haldol (haloperidol)
  • Zyprexa (olanzapine)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Schizoaffective Disorder, Schizophrenia | Phase 4 | Status: COMPLETED